All In MedTech

Device Trial Radar · NCT03511638

Bausch & Lomb Ophthalmic Viscosurgical Device (OVD) Dispersive (DVisc40)

A Study to Document the Safety and Effectiveness of a New OVD When Compared to a Control OVD

Last checked: Nov 20, 2026Latest source record: Oct 22, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 372 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

372

Actual

Start

May 9, 2018

Primary completion

Apr 1, 2019

Study completion Apr 1, 2019

Sponsor

Lead sponsor
Bausch & Lomb IncorporatedNot on our public-company list
Sponsor type
Industry
First posted
Apr 30, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 45 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Study to Document the Safety and Effectiveness of a New OVD When Compared to a Control OVD

Conditions

  • Cataract

Interventions

  • Bausch & Lomb DVisc40Device

    Ophthalmic viscosurgical device

  • Alcon VISCOAT®Device

    Ophthalmic viscosurgical device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change in Mean Epithelial Cell Density (ECD)Time frame: Day 90
  2. Percentage of Participants With Postoperative Intraocular Pressure of at Least 30 mm HgTime frame: 90 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Valeant Site 01

    San Diego, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.